| |
| |
|
| Insider
Information: |
Long Andrew G |
| Relationship: |
EVP, CEO P&HS |
| City: |
Chandler |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
311,855 |
|
|
Indirect Shares
|
115,555 |
|
|
| Direct
Value |
$5,999,825 |
|
|
|
Indirect Value
|
$2,774,476 |
|
|
| Total
Shares |
427,410 |
|
|
| Total
Value |
$8,774,301 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Insys Therapeutics, Inc. |
INSY |
Chief Executive Office... |
2019-04-17 |
62,075 |
2018-08-07 |
0 |
Premium* |
|
|
Owens & Minor Inc |
OMI |
EVP, CEO P&HS |
2024-03-15 |
249,780 |
2023-05-19 |
115,555 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2024-03-15 |
4 |
D |
$24.99 |
$569,397 |
D/D |
(22,785) |
249,780 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,731 |
272,565 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2023-05-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
115,555 |
221,834 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2023-05-15 |
4 |
D |
$18.73 |
$154,822 |
D/D |
(8,266) |
337,389 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2023-05-11 |
4 |
D |
$18.39 |
$132,151 |
D/D |
(7,186) |
345,655 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2023-03-15 |
4 |
D |
$13.06 |
$437,131 |
D/D |
(33,471) |
352,841 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
194,903 |
386,312 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CEO P&HS |
• – – |
2022-11-11 |
4 |
D |
$21.29 |
$158,440 |
D/D |
(7,442) |
191,409 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2022-05-16 |
4 |
D |
$36.05 |
$153,825 |
D/D |
(4,267) |
198,851 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2022-05-11 |
4 |
D |
$37.62 |
$270,300 |
D/D |
(7,185) |
203,118 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,889 |
210,303 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
96,552 |
183,414 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2021-11-12 |
4 |
AS |
$42.27 |
$502,252 |
D/D |
(11,882) |
86,862 |
0 |
% |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2021-11-11 |
4 |
D |
$41.95 |
$244,485 |
D/D |
(5,828) |
98,744 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2021-08-09 |
4 |
AS |
$38.56 |
$442,360 |
D/D |
(11,472) |
104,572 |
0 |
% |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2021-05-11 |
4 |
D |
$33.41 |
$165,079 |
D/D |
(4,941) |
116,044 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,827 |
120,985 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2020-11-11 |
4 |
D |
$22.17 |
$113,466 |
D/D |
(5,118) |
93,158 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
48,276 |
98,276 |
0 |
- |
|
| OMI |
Owens & Minor Inc |
EVP, CFO |
• – – |
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
12,475 |
62,075 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
49,600 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,600 |
20,600 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
